Research advances on the pharmacological effects of tetrandrine

Chinese Journal of Natural Medicines

Volumn 9, Issue 6, 2011, Pages 473-480

  Cai, Xiao Hui ^a   Wang, Shuai ^a   Chen, Bao An ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Anti cancer effect; Calcium blocker; Pharmacological effect; Tetrandrine

Indexed keywords

DEXAMETHASONE; NITROFEN; PLACEBO; TETRAMETHYLPYRAZINE; TETRANDRINE; VERAPAMIL;

ANTIHYPERTENSIVE THERAPY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CARDIOTOXICITY; CONGENITAL DIAPHRAGM HERNIA; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; HEART PROTECTION; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; LIVER FIBROSIS; MEDICAL RESEARCH; NONHUMAN; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PNEUMOCONIOSIS; PORTAL HYPERTENSION; PULMONARY HYPERTENSION; REVIEW; STOMACH DISEASE;

EID: 84855169550     PISSN: 20956975     EISSN: 18755364     Source Type: Journal    
DOI: 10.3724/SP.J.1009.2011.00473     Document Type: Article

References (74)

1. Takemura H, Lmoto K, Ohshika H, et al. Tetrandrine as a calcium antagonist [J]. Clin Exp Pharmacol Physiol 1996, 23:751-753.
2. Wan YC, Liu Y, Liu M, et al. Research advance on the anti-tumour effects of Tetrandrine [J]. Lishizhen Med Mater Med Res 2010, 21(1):212-213.
3. Yi DH, Zheng FL Research overview and application perspective of Tetradrine [J]. Int J Med 2002, 6(9):64-66.
4. Research group of tetrandrine in treating silicosis. Study on the mechanism of tetrandrine in treating silicosis [J]. Chin J Indus Hygiene Occup Dis 1983, 1(3):133-135.
5. Sun DW, Wang Y Observation of therapeutic effect of tetrandrine on pneumoconiosis [J]. Jilin Med J 2009, 30(20):2410-2411.
6. Xu SY Observation of clinical effect of the therapeutic alliance including tetrandrine and Liu Wei Di Huang Wan on pneumosilicosis [J]. Occup Health 2005, 16(5):3-4.
7. Mo X, Chen W, Cheng D Effect of tetrandrine on the collagen contents of lungs in rats with chronic hypoxia [J]. Chin J Tuberc Respir Dis 1998, 21(10):595-597.
8. Wang HL, Kilfeather SA, Martin GR, et al. Effects of tetrandrine on growth factor-induced DNA synthesis and proliferative response of rat pulmonary artery smooth muscle cells [J]. Pulm Pharmacol Ther 2000, 13(2):53-60.
9. Kang J Effects of tetrandrine on pulmonary hypertension in patients with chronic obstructive pulmonary disease [J]. Chin J Tuberc Respir Dis 1993, 16(2):93-94. 124.
10. Ge SR, Cui L, Wang PQ Advances on the pharmacological effects of tetrandrine [J]. Chin Tradit Herb Drugs 2000, 31(8):4-6.
11. Net resources international. Rasilez-innovative treatment for hypertension [OL]. [2011-2-28] http://www.drugdevelopment-technology.com/projects/rasilez/.
12. Qian JQ Cardiovascular pharmacological effects of bisbenzylisoquinoline alkaloid derivatives [J]. Acta Pharmacol Sin 2002, 23(12):1086-1092.
13. Dong HY, Yao C Hypertension treated with isotetrandrine [J]. Chin J Integ Med 1991, 11(2):87-90.
14. Wang MX Xin Bian Shi Yong Yao Wu Xue [M] 2002, 287. Science Press, Beijing. 2nd edition.
15. Huang YT, Cheng YR, Lin HC, et al. Hemodynamic effects of chronic tetrandrine treatment in Sprague-Dawley rats [J]. Chin J Physiol 1997, 40(3):175-178.
16. Dai GZ, Zeng B, Zhang YL, et al. Intravenous tetrandrine in terminationg acute episodes of paroxysmal supraventricular tachycardia [J]. Chin Med J (Engl.) 1990, 103(6):460-463.
17. Qian JQ Cardiovascular pharmacological effects of bisbenzylisoquinoline alkaloid derivatives [J]. Acta Pharmacol Sin 2002, 23(12):1086-1092.
18. Xu M, Sheng L, Zhu X, et al. Protective effect of tetrandrine on doxorubicin-induced cardiotoxicity in rats [J]. Tumori 2010, 96(3):460-464.
19. Pinelli A, Trivulzio S, Brenna S, et al. Pretreatment with tetrandrine has protective effects against isoproterenol-induced myocardial infarction in rabbits [J]. In Vivo 2010, 24(3):265-270.
20. Shen DF, Tang QZ, Yan L, et al. Tetrandrine blocks cardiac hypertrophy by disrupting reactive oxygen species-dependent ERK1/2 signalling [J]. Br J Pharmacol 2010, 159(4):970-981.
21. Zhou HY, Wang F, Cheng L, et al. Effects of tetrandrine on calcium and potassium currents in isolated rat hepatocytes [J]. World J Gastroenterol 2003, 9(1):134-136.
22. Leung YM, Kwan CY, Loh TT Dual effects of tetrandrine on cytosolic calcium in human leukemic HL-60 cells: intracellular calcium release and calcium influx blockade [J]. Brit J Pharmacol 1994, 113:767-774.
23. Liu QY, Li B, Gang JM, et al. Tetrandrine, a Ca21 antagonist: effects and mechanisms of action in vascular smooth muscle cells [J]. J Pharmacol Exp Ther 1995, 273:32-39.
24. Liu ZX The analysis of clinical effect and treatment cost with the therapeutic alliance of Hypophysin and tetrandrine on esophagus-gastric fundus variceal bleeding [J]. J Chin Phys 2006, 29(11):64-65.
25. 2+ channel inhibitor on hepatic fibrosis [J]. Chin J Intern Med 1990, 29(8):453-456.
26. Li D, Lu H, Li X, et al. Calcium channel blockers in cirrhotic patient with portal hypertension [J]. Chin Med J (Engl.) 1995, 108(11):803-808.
27. Wang ZR, Li DG, Lu HM Advances on the pharmacologic mechanism and the exploratory development of tetrandrine in diseases of digestive system [J]. Chin J Gastroenterol Hepatol 2001, 10(3):281-283.
28. Qin DL Advances on the pharmacology and the exploratory development of tetrandrine in diseases of digestive system [J]. J Luzhou Med Coll 2005, 28(4):379-380.
29. Li SY, Teh BS, Seow WK, et al. Effect of tetrandrine on immunological responses and cardiac transplant rejection in mice [J]. Int Arch Allergy Appl Immunol 1989, 90(2):169-173.
30. Whitehouse MW, Fairlie DP, Thong YH Anti-inflammatory activity of the isoquinoline alkaloid, tetrandrine, against established adjuvant arthritis in rats [J]. Agents Actions 1994, 42(3-4):123-127.
31. Ferrante A, Seow WK, Rowan-Kelly B, et al. Tetrandrine, a plant alkaloid, inhibits the production of tumour necrosis factor-alpha (cachectin) hy human monocytes [J]. Clin Exp Immunol 1990, 80(2):232-235.
32. Xiao JG, Chiou GC Tetrandrine inhibits breakdown of blood-aqueous barrier induced by endotoxin and interleukin-1 alpha in rats [J]. J Ocul Pharmacol Ther 1996, 12(3):323-329.
33. Lai JH, Ho LJ, Kwan CY, et al. Plant alkaloid tetrandrine and its analog block CD28-costimulated activities of human peripheral blood T cells: potential immunosuppressants in transplantation immunology [J]. Transplantation 1999, 68(9):1383-1392.
34. Lieberman I, Heil BV, Seow WK, et al. Synergy between tetrandrine and FK506 in prevention of diabetes in BB rats [J]. Life Sci 1993, 53(26):453-458.
35. Pang L, Hoult JR Cytotoxicity to macrophages of tetrandrine, an antisilicosis alkaloid, accompanied by an overproduction of prostaglandins [J]. Biochem Pharmacol 1997, 53(6):773-782.
36. Lai YL, Chen YJ, Wu TY, et al. Induction of apoptosis in human leukemic U937 cells by tetrandrine [J]. Anticancer Drugs 1998, 9(1):77-81.
37. Dong Y, Yang MM, Kwan CY In vitro inhibition of proliferation of HL-60 cells by tetrandrine and coriolus versicolor peptide derived from Chinese medicinal herbs [J]. Life Sci 1997, 60(8):135-140.
38. Lai JH, Ho LJ, Lu KC, et al. Western and Chinese antirheumatic drug-induced T cell apoptotic DNA damage uses different caspase cascades and is independent of Fas/Fas ligand interaction [J]. J Immunol 2001, 166(11):6914-6924.
39. Ho LJ, Lai JH Chinese herbs as immunomodulators and potential disease modifying antirheumatic drugs in autoimmune disorders [J]. Curr Drug Metab 2004, 5(2):181-192.
40. Shen XF, Qiu XS The control study of tetrandrine and tetramethylpyrazine treating connective tissue disease combined with PAH [J]. Chin Rem Clin 2007, 7(1):31-33.
41. Shen YC, Chen CF, Wang SY, et al. Impediment to calcium influx and reactive oxygen production accounts for the inhibition of neutrophil Mac-1 up-regulation and adhesion by tetrandrine [J]. Mol Pharmacol 1999, 55(1):186-193.
42. Li YY, Li XL, Yang CX, et al. Effects of tetrandrine and QYT on ICAM-1 and SOD gene expression in pancreas and liver of rats with acute pancreatitis [J]. World J Gastroenterol 2003, 9(1):155-159.
43. Jiang R Effects of immunological regulation and the application of tetrandrine in organ transplantation [J]. World Notes Tradit Chin Med 2003, 25(5):67-69.
44. Business Standard Caner to become the leading cause of death worldwide: report [OL]. Press Trust of India/Boston (2010-8-17) [2011-2-27] http://www.business-standard.com/india/news/cancer-to-becomeleading-causedeath-worldwidereport/105458/on.
45. He BC, Gao JL, Zhanag BQ, et al. Tetrandrine inhibits Wnt/β-catenin signaling and suppresses tumor growth of human colorectal cancer [J]. Mol Pharmacol 2011, 79(2):211-219.
46. Chen Y, Tseng SH The potential of Tetrandrine against gliomas [J]. Anticancer Agents Med Chem 2010, 10(7):534-542.
47. Lee JH, Kang GH, Kim KC, et al. Tetrandrine-induced cell cycle arrest and apoptosis in A 549 human lung carcinoma celld [J]. Int J Oncol 2002, 21(6):1239-1244.
48. Li X, Su B, Liu R, et al. Tetrandrine induces apoptosis and triggers caspase cascade in human bladder cancer cells [J]. J Surg Res 2011, 166(1):e45-e51.
49. Meng LH, Zhang H, Hayward L, et al. Tetrandrine induces early G1 arrest in human colon carcinoma cells by down-regulating the activity and inducing the degradation of G1-S-specific cyclin-dependent kinases and by inducing p53 and p21 Cip1 [J]. Cancer Res 2004, 64(24):9086-9092.
50. Xu WL, Shen HL, Ao ZF, et al. Combination of tetrandrine as a potential reversing agent with daunorubicin, etoposide and cytarabine for the treatment of refractory and relapsed acute myelogenous leukemia [J]. Leuk Res 2006, 30(4):407-413.
51. Chen B, Yin L, Cheng J, et al. Effect of D, L-threo-1-phenyl-2- decanoylamino-3-morpholino-1-propanol and tetrandrine on the reversion of multidrug resistance in K562/A02 cells [J]. Hematology 2011, 16(1):24-30.
52. Chen BA, Li J, Cheng J, et al. Effect of tetrandrine combined with daunorubicin on expression of P21 and P-gp in K562/A02 cells [J]. J Exp Hematol, 17 (5): 1179-1182.
53. Li J, Chen BA, Zhu MS, et al. Influence of tetrandrine on sorcin gene expression in K562/A02 cell line [J]. J Exp Hematol 2008, 16(1):65-69.
54. Chen BA, Su AL, Cheng J, et al. Effects of tetrandrine on nuclear factor-kappaB expression in leukemia multidrug-resistant cell line K562/A02 [J]. J Chin Inter Med 2008, 6(9):956-959.
55. Liu ZL, Hirano T, Tanaka S, et al. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells [J]. J Pharm Pharmacol 2003, 55(11):1531-1537.
56. Zhu XL, Xu WL, Lü XJ, et al. Mechanism of preventive effect of tetrandrine on acquired multidrug resistance in K562 cells [J]. J Exp Hematol 2011, 19(2):363-366.
57. Gao LS Tetrandrine combined with small dose of radiotherapy treatment on 97 patients of lung cancer [J]. J Tradit Chin Med 1980, 34(8):37-39.
58. Tian QZ, Han XL, Sun XC Tetrandrine sensitizing radiotherapy on breast carcinoma [J]. J Southeast Univ: Med Sci Ed 2005, 4:233-236.
59. Chen Y, Chen JC, Tseng SH Effects of tetrandrine plus radiation on neuroblastoma cells [J]. Anticancer Res 2009, 29(8):3163-3171.
60. Oehler MK, Bicknell R The promise of antiangio genic cancet therapy [J]. Br J Cancer 2000, 82(4):2749-2750.
61. Kohn EC, Alessandro R, Spoonster J, et al. Angiogenesis: role of calcium-mediated signal transduction [J]. Proc Natl Acad Sci USA 1995, 92(5):1307-1311.
62. Kobayashi S, Inaba K, Kimura I, et al. Inhibitory effects of tetrandrine on angiogenesis in adjuvant-induced chronic inflammation and tube formation of vascular endothelial cells [J]. Biol Pharm Bull 1998, 21(4):346-349.
63. Kobayashi S, Kimura I, Fukuta M, et al. Inhibitory effects of tetrandrine and related synthetic compounds on angiogenesis in streptozotocin-diabetic rodents [J]. Biol Pharm Bull 1999, 22(4):360-365.
64. Wang Y, Liu W, Lin H Effect and significance of tetrandrine on epidermal growth factor and its receptor in the lung of congenital diaphragmatic hernia rat model [J]. Chin J Repar Reconstr Surg 2006, 20(11):1109-1113.
65. Xu C, Liu W, Wang Y, Chen Z, et al. Prenatal tetrandrine treatment can reverse the abnormal conditions in the lung of newborn with congenital diaphragmatic hernia [J]. Med Hypotheses 2009, 72(5):570-573.
66. Ji Y, Liu WY, Chen SY, et al. Protective effects of tetrandrine against congenital diaphragmatic hernia in rats [J]. Chin J Contemp Pediatr 2011, 13(5):401-405.
67. Seow WK, Ferrante A, Li SY, et al. Suppression of human monocyte interleukin-1 production by the plant alkaloid tetrandrine [J]. Clin Exp Immunol 1989, 75(1):47-51.
68. Xiao JG, Wang Y, Wu S, et al. Inhibitory effect of tetrandrine on lens proteins-induced ocular inflammation in rabbits [J]. J Ocul Pharmacol 1992, 8(4):309-315.
69. Xiao JG, Chiou GCY Tetrandrine inhibits breakdown of blood-aqueoua barrier induced by endotoxin and interleukin-1 alpha in rats [J]. J Ocul Pharmacol Ther 1996, 12(3):323-329.
70. Guo LJ, Zhang XF, Zhang S An experimental study of inhibition of tetrandrine on posterior capsular opacification in rabbits [J]. Chin J Ophthalmol 2002, 38(4):235-238.
71. Huang P, Xu YS, Wei RX, et al. Efficacy of Tetrandrine on lowering intraocular pressure in animal modeo with ocular hypertension [J]. J Glaucoma 2011, 20(3):183-188.
72. Liang XC, Hgino N, Guo SS, et al. Therapeutic efficacy of Stephania tetrandrina S. Moore for treatment of neovascularization of retinal capillary (retinopathy) in diabetes- in vitro study [J]. Phytomedicine 2002, 9(5):377-384.
73. Xu HP, Wang CY, Zhu HC, et al. The inhibitory efficacy of Tetrandrine and vincristine on the growth of retinoblastoma cell line HXO-Rb44 [J]. J Tradit Chin Ophthalmol 1995, 5:67-69.
74. Wang G, Lemos JR, Iadecola C Hebal alkaloid tetrandrine: fron an ion channel blocker to inhibitor of tumor proliferation [J]. Trends Pharmacol Sci 2004, 25(3):120-123.